Research Article
Long-Term Exercise and Risk of Metabolic and Cardiac Diseases: The Erlangen Fitness and Prevention Study
Table 2
Per protocol analysis: changes in the exercise and control groups for primary and secondary study endpoints.
| | Exercise MV (SD)
| Control MV (SD)
| Absolute difference MV (95% CI) | P | Effect size (d) |
| 10-year CHD risk | Baseline (%) | | | — | — | — | 12 y follow-up (%) | | | 3.89 | — | — | Risk changes (%) | | | 2.75 (1.61 to 3.89) | 0.001 | 0.90 |
| Metabolic syndrome Z-score | Baseline (%) | | | — | — | — | 12 y follow-up (%) | | | — | — | — | Changes (%) | | | 2.03 (1.42 to 2.64) | 0.001 | 1.36 |
| 10-year myocardial infarction/cardiac death risk (hard 10-year CHD risk) | Baseline (%) | | | — | — | — | 12 y follow-up (%) | | | — | — | — | Risk changes (%) | | | 1.20 (0.68 to 1.71) | 0.001 | 0.97 |
|
|
Significance (P) for within-group effects: , . Exact significance values are listed in the Result Section.
|